New Key Statistics Module, Z-Score and F-Score
NYSE:NVO Key Ratios
Market Cap $ M | 512,221.08 |
Enterprise Value $ M | 511,393.40 |
P/E(ttm) | 39.55 |
PE Ratio without NRI | 39.55 |
Forward PE Ratio | 27.19 |
Price/Book | 30.69 |
Price/Sales | 13.43 |
Price/Free Cash Flow | 52.51 |
Price/Owner Earnings | 30.42 |
Payout Ratio % | 0.47 |
Revenue (TTM) $ M | 37,383.00 |
EPS (TTM) $ | 2.91 |
Beneish M-Score | -2.76 |
10-y EBITDA Growth Rate % | 11.70 |
5-y EBITDA Growth Rate % | 17.50 |
y-y EBITDA Growth Rate % | 52.90 |
EV-to-EBIT | 30.28 |
EV-to-EBITDA | 26.38 |
PEG | 2.26 |
Shares Outstanding M | 4,451.00 |
Net Margin (%) | 34.84 |
Operating Margin % | 43.20 |
Pre-tax Margin (%) | 43.77 |
Quick Ratio | 0.75 |
Current Ratio | 0.94 |
ROA % (ttm) | 28.75 |
ROE % (ttm) | 89.64 |
ROIC % (ttm) | 28.52 |
Dividend Yield % | 1.25 |
Altman Z-Score | 10.29 |
NVO Number of Guru Trades
NVO Volume of Guru Trades
Gurus Latest Trades with NYSE:NVO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:NVO is held by these investors
Total 6
Novo Nordisk AS Insider Transactions
No Available Data
News about NYSE:NVO
Total 0- 1